Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: RenJi Hospital
Condition: Upper Urinary Tract Urothelial Carcinoma, Kidney Preservation, HER-2 ADC, PD-1antibody
NCT05912816
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: primary_completion_date_past_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.